Back to search
FDAFDA · Food and drugs·Recall number D-0129-2018

Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only Compounded by: Premier Pharmacy Labs., Inc. 8265 Commercial Way Weeki Wachee, FL 34613, NDC# 69623-234-15

Published December 27, 2017 · Recall initiated: August 10, 2017

Summary

FDA records drug Class II recall D-0129-2018, published December 27, 2017 and initiated August 10, 2017. Recalling firm: Premier Pharmacy Labs Inc; Status: Terminated; Reported quantity: 1610 syringes; Lot: Lot # NEO071317MMDSA BUD: 01/19/2018 Lot # NEO071317MMDSC BUD: 01/19/2018 Lot # NEO071317MMDSF BUD: 01/19/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Premier Pharmacy Labs Inc
Distributor
Michigan, Maryland, Minnesota, North Carolina, Ohio, Florida
Lot
Lot # NEO071317MMDSA BUD: 01/19/2018 Lot # NEO071317MMDSC BUD: 01/19/2018 Lot # NEO071317MMDSF BUD: 01/19/2018
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only Compounded by: Premier Pharmacy Labs., Inc. 8265 Commercial Way Weeki Wachee, FL 34613, NDC# 69623-234-15 recalled?

Yes. FDA published recall D-0129-2018 on December 27, 2017. Reported hazard: Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.

What should I do if I have this product?

Voluntary: Firm initiated · Letter